Ann: Investor Trading Update, page-2

Brilliant - well on track to exceed 200%. Financials are looking really strong.

There is plenty of cash in the bank however I do fear that these roadshows are possibly a precursor to a CR.

Reason I suggest this is that the UK has moved from scientific evaluation to a trail implementation for inclusion into the NHS.

Could a formal expansion into the UK be on the cards?

The company were targeting that US would be the biggest market because of the legislative need to inform women of density. I believe that the rest of the world may be catching on - after all they now have presence in all major Australian countries.

It is also interesting that 55% is held by retail investors and 40% by management- institutional investors don’t really show other than Craig’s investment partners who are in the town 20.

2018 may see a significant appreciation in the SP